Keyphrases
K-ATPase
100%
Cardiovascular Pharmacotherapy
64%
Ouabain
57%
European Society of Cardiology
56%
Skeletal muscle
36%
Digoxin
35%
Plasma Potassium
32%
Na +
32%
Left Ventricle
30%
Hyperkalemia
25%
Potassium Homeostasis
24%
Digitalis Glycosides
24%
Medical Research
24%
Hypokalemia
24%
Potassium Concentration
20%
Binding Site
18%
Patients with Cardiovascular Diseases
18%
Human Skeletal muscle
17%
During Exercise
16%
Randomized Clinical Trial
16%
Long QT Syndrome
16%
ATP Synthase
16%
Potassium Levels
16%
Europe
16%
Pharmacogenomics
16%
Potassium
15%
Wet Weight
15%
Binding Site Concentration
13%
Digitalize
12%
Heart Failure
12%
Vanadate
12%
Human Heart
12%
Clinical Trials
12%
Cardiovascular Therapy
12%
Digitalis
11%
Extrarenal
11%
Ventricular Arrhythmia
11%
Cardiovascular Disease
10%
Sudden Cardiac Death
10%
Antibody Fragment
10%
K+ Content
9%
End-stage Heart Failure
9%
Exercise Bout
9%
K+ Homeostasis
8%
Heart Disease
8%
Hemodialysis
8%
Diabetes
8%
Muscle Sample
8%
Sudden Infant Death Syndrome
8%
Effect of Potassium
8%
Medicine and Dentistry
Cardiovascular System
49%
Cardiology
48%
Drug Therapy
48%
Adenosine Triphosphatase (Potassium Sodium)
30%
Heart Failure
26%
Potassium Ion
26%
Potassium Homeostasis
23%
Cardiovascular Disease
18%
Pharmacogenomics
16%
Hyperkalemia
16%
Atrial Fibrillation
16%
Long QT Syndrome
16%
Hypokalemia
16%
Skeletal Muscle
16%
Digoxin
14%
Digitalization
13%
Ouabain
11%
Left Ventricle
11%
Sudden Cardiac Death
10%
Heart Disease
10%
Apoplexy
10%
Clinical Trial
9%
Receptor
9%
Meta-Analysis
8%
CHA2DS2-VASc Score
8%
Systematic Review
8%
T-Peak to T-End
8%
Limb
8%
Renin Angiotensin Aldosterone System
8%
Heart Repolarization
8%
Peripheral Vascular Disease
8%
Artery Disease
8%
Antithrombotic Therapy
8%
Pathophysiology
8%
HERG
8%
Potassium Ion
8%
Sudden Death
8%
Anticoagulation
8%
Statin
8%
End Stage Renal Disease
8%
Randomized Clinical Trial
8%
Sudden Infant Death Syndrome
8%
Endotoxemia
8%
Lactic Acid
8%
Sodium Ion
8%
Adenosine Triphosphatase
8%
Ion Channel
8%
T Wave
7%
Placebo
5%
Pharmacology, Toxicology and Pharmaceutical Science
Isotopes of Potassium
49%
Pharmacotherapy
48%
Adenosine Triphosphatase (Potassium Sodium)
27%
Heart Failure
27%
Hyperkalemia
24%
Ouabain
19%
Cardiovascular Disease
17%
Randomized Clinical Trial
16%
Adenosine Triphosphatase
16%
Sodium Ion
16%
Hypokalemia
16%
Digoxin
16%
Anticoagulant Agent
13%
Clinical Trial
11%
Receptor
11%
Binding Site
9%
Sudden Cardiac Death
9%
Heart Arrhythmia
8%
Aldosterone
8%
Digoxin Antibody
8%
Terbutaline
8%
Adrenergic Receptor Stimulating Agent
8%
Hemodialysis
8%
Long QT Syndrome
8%
Pathophysiology
8%
Peripheral Vascular Disease
8%
Artery Disease
8%
Renin
8%
Angiotensin
8%
Sudden Death
8%
Antithrombotic Therapy
8%
Polypharmacy
8%
Statin (Protein)
8%
Tachycardia
8%
Atrial Fibrillation
8%
Digitalis Glycoside
8%
Pharmacogenomics
8%
Aortic Valve Disease
8%
Potassium Ion
7%
Disease
5%
Thromboembolism
5%
Multiple Chronic Conditions
5%
